Approval · Notice of Compliance 34808 · 2025
ZYNYZ: Notice of Compliance 34808
Issued February 6, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34808
- Date
- February 6, 2025
- Company
- Incyte CorporationWilmington, Delaware, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZYNYZ | 02555239 | Marketed |
Medicinal ingredients
- RETIFANLIMAB 25 MG per ML